A G García Selected Research

A G García Research Topics

Disease

3	Brain Ischemia (Cerebral Ischemia) 04/2014 - 01/2003
3	Alzheimer Disease (Alzheimer's Disease) 02/2012 - 06/2002
2	Ischemia 04/2014 - 01/2003
2	Stroke (Strokes) 04/2014 - 01/2003
2	Osteoarthritis 06/2010 - 05/2010
2	Necrosis 06/2010 - 05/2010
2	Cognitive Dysfunction 10/2002 - 06/2002
1	Disease Progression 09/2017
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2014
1	Brain Injuries (Brain Injury) 02/2012
1	Hypoxia (Hypoxemia) 02/2012
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2010
1	Uveitis 06/2010
1	Neuroblastoma 06/2010
1	Inflammation (Inflammations) 05/2010
1	Neuroinflammatory Diseases 05/2010
1	Myocardial Infarction 02/2008
1	Pain (Aches) 04/2004
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2003
1	Infarction (Infarctions) 01/2003
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2002
1	Dementia (Dementias) 10/2002
1	Memory Disorders (Memory Loss) 10/2002
1	Brain Diseases (Brain Disorder) 10/2002
1	Agranulocytosis (Granulocytopenia) 06/2002
1	Migraine Disorders (Migraine) 01/2001
1	Pheochromocytoma 06/2000
1	Hypertensive Crisis 06/2000
1	Neoplasms (Cancer) 06/2000

Drug/Important Bio-Agent (IBA)

3	Neuroprotective AgentsIBA 04/2014 - 01/2003
2	Glucose (Dextrose)FDA LinkGeneric 04/2014 - 02/2012
2	Oxygen (Dioxygen)IBA 04/2014 - 02/2012
2	Galantamine (Galanthamine)FDA LinkGeneric 02/2012 - 06/2002
2	Pharmaceutical PreparationsIBA 02/2012 - 06/2002
2	Chondroitin Sulfates (Chondroitin Sulfate)IBA 06/2010 - 05/2010
2	NF-kappa B (NF-kB)IBA 06/2010 - 05/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2010 - 05/2010
2	Cholinergic Agents (Cholinergics)IBA 01/2004 - 06/2002
2	Cytidine Diphosphate Choline (Citicoline)IBA 01/2003 - 10/2002
1	Glutamic Acid (Glutamate)FDA Link 07/2014
1	Hyaluronic Acid (Hyaluronan)IBA 04/2014
1	DisaccharidesIBA 04/2014
1	NADPH Oxidases (NAD(P)H oxidase)IBA 02/2012
1	EnzymesIBA 06/2010
1	AntioxidantsIBA 06/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2010
1	LipopolysaccharidesIBA 05/2010
1	Messenger RNA (mRNA)IBA 05/2010
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2010
1	Dihydrotachysterol (AT 10)IBA 05/2010
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 02/2008
1	Epinephrine (Adrenaline)FDA LinkGeneric 02/2008
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2004
1	Opioid Analgesics (Opioids)IBA 04/2004
1	Neuropeptide YIBA 04/2004
1	NeuropeptidesIBA 04/2004
1	NeurotensinIBA 04/2004
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2004
1	Substance PIBA 04/2004
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 04/2004
1	Vasopressins (Vasopressin)IBA 04/2004
1	Nimodipine (Modus)FDA LinkGeneric 01/2003
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 06/2002
1	AcetylcholinesteraseIBA 06/2002
1	Calcium DobesilateIBA 06/2002
1	dotarizineIBA 01/2001
1	CatecholaminesIBA 06/2000
1	Calcium Channels (Calcium Channel)IBA 06/2000

Therapy/Procedure

1	Gastrostomy 09/2017
1	Ligation 01/2003
1	Injections 01/2003